KRAS plays a pivotal role in transmitting signals from cell surface receptors to the nucleus, and dysregulation or mutations in the KRAS gene are commonly linked to various cancers, particularly colorectal cancer, underscoring its significance as a target for cancer research and therapeutic interventions [75, 81]. Here, CD177 is linked to colorectal cancer.